Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pivotal phase III trial of RSR-13 completes enrollment

Aug. 9, 2002

Little or no activity for KW-2189 in advanced malignant melanoma

Aug. 9, 2002

Servier researchers identify new metalloproteinase inhibitors

Aug. 8, 2002

Bayer claims new PDE10A inhibitors and their use in cancer

Aug. 8, 2002

AstraZeneca completes Iressa NDA for NSCLC

Aug. 8, 2002

Positive results for ursodiol in colorectal cancer

Aug. 8, 2002

Introgen to file European Advexin marketing application in 2004

Aug. 8, 2002

Atrix submits IND for new dosage form of Eligard

Aug. 8, 2002

Patient enrollment completed for phase III clinical trial with Tarceva

Aug. 7, 2002

Potential role for CEP-701 in the treatment of acute myeloid leukemia

Aug. 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.